We found that mir-4728 was a unique miRNA with the most significant and highest expression in HER2-positive breast cancer patients (Figure 1A; Supplementary Material S1), with a fold-change up to 4.37 (Figure 1B). Here, ERBB2 is linked to breast carcinoma.